Regulations for Advertising Cannabis in the USA

The rest of the states have either passed laws legalizing medical marijuana consumption or marijuana consumption continues to be unlawful, but many states are starting to develop marijuana advertising regulations. Anyone who’s interested in marketing and advertising cannabis in compliance with state laws will benefit from this presentation. 
In this webinar expert speaker Norma Skolnik, will discuss that if you have a crystal-clear understanding of the regulatory requirements for advertising your cannabis business and products, so how you can comply with the laws confidently—anywhere in the U.S.! 


Session Highlights: 
  • Status of current U.S. federal Marijuana law 
  • Marijuana Justice Act & Schumer legislation on decriminalization of Marijuana use 
  • State laws on Marijuana advertising in Alaska, California, Colorado, Oregon, Massachusetts, Maine, Nevada and Washington and others. 
  • District of Columbia regulation of Marijuana usage & advertising 
  • Implications of FDA Seeking Public Opinion on Cannabis Following WHO Request 
Why You Should Attend: 
In this webinar understand the current federal marijuana law—as well as all the key state regulations on cannabis advertising. Speaker will also explain how to navigate tricky markets such as Washington, D.C. 
Who Should Attend: 
  • Regulatory affairs personnel 
  • Directors and associates 
  • Product managers 
  • Marketing managers 
  • Advertising professionals 

*You may ask your Question directly to our expert during the Q&A session. 
** You can buy On-Demand and view it as per your convenience.

Comments

Post a Comment

Popular posts from this blog

Construction Risk Management with Current Issues & Real Life Examples

Construction projects entail considerable risk. Profit margins are relatively low when compared to the investment made, and often estimates of cost can only be based on best guesses. Therefore, it is critical to manage and minimize the exposure to risk. Fortunately, there are several opportunities in the life of a project that allow for significant risk management . These opportunities start with the decision of whether or not to bid, and following through to the bidding, subcontracting, and management phases. In this webinar Expert Speaker Fritz Marth will explore the risk management strategies that can be employed at the various times, and in the various aspects, of a construction project. Using real-life examples, Speaker will also explore the successful implementation of these methods, as well as instances where a failure to manage risk resulted in unsuccessful outcomes. Session Highlights:  Assessing whether or not to bid a project Developing an adequate bid Properly p
Read more

Importance of Quality as Work Culture in Food & Pharmaceuticals Manufacturing

Good manufacturing practices, developed in the past 20 years, have introduced new hygienic rules that limit contamination by pathogenic and spoilage bacteria. Consumers are more aware of the quality and storage of meat and of the safety measures taken during its preparation. However, several criteria other than eating quality play an important role in meat acceptability, e.g., price of meat, attitudes and knowledge of consumers towards meat, and convenience in preparing meat.  “ It’s difficult to find anyone who says food safety is not important, but people don’t always realize that when you do good for food safety, you do good for the business ,” Hernandez said. … “ A strong food safety program and discipline provide benefits that go well beyond food safety. ” These are the key factor of Food Safety Standards: Food Safety is Good for Business Impact on Businesses & Study Hazard Analysis & Critical Control Point GMP In Food Industry Food Safety Is Good For Bus
Read more
Overview of  FDA computer system  validation requirements, including 21 CFR Part 11 compliance FDA requires that all computer systems that handle data regulated by the Agency to be validated in accordance with their guidance on computerized systems. This guidance was first issued in 1983, and the main points of focus remain consistent today, despite the number of years that have passed and the technology changes that have taken place. The guidance was revisited for its application to the medical device industry, as the first issuance addressed pharmaceuticals. In 1997, 21 CFR Part 11 was issued to address electronic records and signatures, as many laboratories and other FDA-regulated organizations began seeking ways to move into a paperless environment. This guidance has been modified over the years to make it more palatable to industry, and this includes discretionary enforcement measures. The intent was to avoid creating a huge regulatory compliance cost to industry that was in
Read more